Professor | Associate Member
Mount Sinai Hospital
diabetes, clinical trials, vascular function, intense insulin therapy
Not currently accepting students
Dr. Ravi Retnakaran’s clinical research program focuses on the early pathophysiology of type 2 diabetes and cardiovascular disease.
Other areas of interest in his research program include the evaluation of pancreatic beta-cell function in clinical studies and clinical trials involving short-term insulin therapy early in the course of type 2 diabetes in order to prevent the progression of this condition.